Sign in
Taking people in NetherlandsPhase 1

Imaging test with FAPI to identify a colorectal cancer subtype

Tests a FAPI scan in adults with colorectal cancer spread to the liver.

Key facts

Who runs it
Universitair Medisch Centrum Utrecht
Where
Utrecht, NetherlandsSee the site
Registry title
Molecular imaging with FAPI for diagnosing the CSM4 colorectal cancer subtype
Status
Recruiting
Phase
Phase 1
People taking part
45 people, planned
Started
1 Aug 2024
Expected to end
28 Jul 2031
Type of study
Interventional
Record updated
12 September 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with colorectal cancer that has spread to the liver. It studies FAPI molecular imaging to find the CSM4 colorectal cancer subtype.

Age
18 years or older
Sex
All sexes can join.
Disease stage
Colorectal cancer with liver metastases.

Where in Netherlands

  • Universitair Medisch Centrum UtrechtUtrecht, NetherlandsTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record

Print a page for my doctor

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).
Plain-language title
Imaging test with FAPI to identify a colorectal cancer subtypeGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 9 November 2026.
Record updated
12 September 2025